AUSTRALIAN Cancer Technology has appointed two US medical scientists to its scientific advisory board.
Rick Phipps and Professor Kerry O’Banion, both from the University of Rochester School of Medicine will join neuroscientist Professor David Felten and oncologist Professor Barry Body on the advisory board.
Professor Phipps, an immunologist and cancer researcher with interests in lung diseases and lymphomas is the director of the university’s lung biology and diseases program.
Professor O’Banion, associate professor of neurobiology and anatomy, is internationally known for his work on cyclooxgenase-2 and its critical role in neuroinflammation and neurodegenerative diseases. He is a co-holder of the patents for the use of COX-2 inhibitors.
© Business News 2018. You may share content using the tools provided but do not copy and redistribute.